ライフサイエンスコーパス: female patient

1 nt 1 or more surgical procedures (55.1% were female patients).

2 t histopathologic findings for a 74-year-old female patient.

3 expression response was similar in male and female patients.

4 la to the posterior thalamus in male but not female patients.

5 ts, 5.3% black male patients, and 3.8% black female patients.

6 ed higher activity in the left amygdala than female patients.

7 BMI was increased in 60% of female patients.

8 ignificantly more important among colorectal female patients.

9 Costs are about 50% higher in fertile-age female patients.

10 ns, 1-year adjusted survival was superior in female patients.

11 d 0.28 +/- 0.05 times the thoracic width for female patients.

12 rstand differences in responses in males and female patients.

13 th lower concentrations for male compared to female patients.

14 g polypeptide has been reported with PTSD in female patients.

15 milial risk or heritability between male and female patients.

16 There were 17 male and 13 female patients.

17 erapy efficacy is different between male and female patients.

18 Similar results were obtained for female patients.

19 ia patients as compared to the 32-depressive female patients.

20 erapy efficacy is different between male and female patients.

21 There were 9 male and 6 female patients.

22 te and developmental defects in heterozygous female patients.

23 no statistically significant association in female patients.

24 disease outcome in male patients, but not in female patients.

25 rophy was reported in 73% of male and 74% of female patients.

26 The cohort comprised 30 male and 27 female patients.

27 ificant in the subgroup analysis of male and female patients.

28 his analysis, 3973 (53%) male and 3582 (47%) female patients.

29 e to previously published upstaging rates in female patients.

30 needs such as contraception and pregnancy in female patients.

31 vels, patients with affective psychosis, and female patients.

32 outcomes than those of ERbeta-negative NSCLC female patients.

33 ontal cortices compared with healthy men and female patients.

34 exposed to ICM [mean age, 7 years +/- 6; 484 female patients]).

35 ars old than >/=10 years old (odds ratio for female patients, 0.67; 95% CI, 0.58-0.78; odds ratio for

36 Male sex (rate ratio [RR] for male vs female patients 1.8 [95% CI 1.7-2.0]), younger age (RR f

37 as reported by nine partners (10.3%) and two female patients (11.8%), and three patients (2.0%) repor

38 with large differences seen between male and female patients (15% lower for women in same age group).

39 ; interquartile range [IQR], 9-15 years; 235 female patients; 167 male patients) were included.

40 of chromosome X was detected exclusively in female patients (17.1%).

41 n age of 26.7 years [range, 16-53 years]; 18 female patients (19 hips) with a mean age of 28.9 years

42 s (mean [SD] age, 62.8 [13.4] years; 12 were female patients), 20 eyes without DR from 11 diabetic pa

43 A histopathologic data set (n = 368; 144 female patients, 224 male patients) was used to validate

44 k female patients (44.1%), followed by white female patients (38.4%), black male patients (36.4%), an

45 ming is the severely compromised survival of female patients (4-year relative survival females 0.78,

46 om January 1, 1998, to December 31, 2012, of female patients 40 to 99 years of age with a clinical di

47 d rehospitalization were highest among black female patients (44.1%), followed by white female patien

48 (63 years +/- 5.2 [standard deviation], 261 female patients), 448 of whom had lung nodules that were

49 younger (58 v 68 years, respectively), fewer female patients (46% v 65%, respectively), and patients

50 , 4.1]; 1327 non-Hispanic white [76.0%]; 867 female patients [49.7%]), and 272 had type 2 (mean age,

51 were 66.6% white male patients, 24.3% white female patients, 5.3% black male patients, and 3.8% blac

52 Results Seven male patients (50%) and seven female patients (50%) (mean age, 16 years; range, 13-18

53 D] patient age, 65.74 [12.32] years; 5975798 female patients 56.60%]) for major noncardiac surgery, p

54 SD, 3.5]; 72 non-Hispanic white [26.5%]; 181 female patients [66.5%]).

55 The molecular profiles for 99 patients (30 female patients, 69 male patients) were identified from

56 standard deviation]; 92 male patients and 45 female patients; 83 paroxysmal and 54 persistent) who un

57 e +/- standard deviation, 8 years +/- 6; 484 female patients]; 925 unexposed to ICM [mean age, 7 year

58 le patients were more likely to succeed than female patients (adjusted odds ratio [aOR], 9.83; 95% co

59 ulmonary benign metastasizing leiomyoma in a female patient admitted to our hospital with suspicion o

60 ratio, 0.29; 95% CI, 0.11-0.77; p < 0.01) in female patients after dexamethasone administration.

61 Twelve female patients (age range, 19-54 years; mean age, 41.2

62 with thalamic electrodes (nine male and one female patients, age: 34-74 years).

63 c or subthalamic electrodes (13 male and two female patients, age: 50-77 years) and 10 patients with

64 Male and female patients aged 18 through 55 years (18-60 years fo

65 entified 330 pregnant and 10 562 nonpregnant female patients aged 18 to 44 years with HS in Get With

66 en-label, non-inferiority trial, we enrolled female patients (aged 11-18 years) with anorexia nervosa

67 l, dose-escalation study in the UK, male and female patients (aged 18 years or older) with Friedreich

68 There were 2 white female patients and 1 African American male patient.

69 Three female patients and 1 male patient underwent iris tumor

70 A total of 22 eyes from 16 female patients and 1 male patient with foveomacular sch

71 There were 12, 7, and 8 female patients and 13, 6, and 6 male patients in the iS

72 1 years +/- 14 [standard deviation {SD}]; 68 female patients and 77 male patients) with stage IV CRC

73 Both male and female patients and controls were tested.

74 otentially lethal complication, is higher in female patients and in older adults with untreated defec

75 situations as safe, uncertain, or risky, but female patients and mothers rated fewer situations as sa

76 w-up period of 9.3 years, 227 women (9.9% of female patients) and 129 men (20% of male patients) with

77 DTI in 69 patients with mTBI (47 male and 22 female patients) and 21 control subjects (10 male and 11

78 ; age range, 10-22 years; nine male and four female patients) and one additional comparative patient

79 ts (mean [SD] age, 58.8 [10.1] years; 5 were female patients), and 16 eyes from 12 healthy age-matche

80 y-two patients had XLP (9.7%; 10 male and 12 female patients), and 9 patients (4.0%) had elevated ePP

81 tient and outpatient settings, from male and female patients, and across age groups from 18 to 89 yea

82 Female patients appear to be less aroused through reject

83 nia compared with healthy controls, and that female patients are at greater risk than male patients.

84 However, in female patients, beneficial effects on the occurrence of

85 All TV NOTES procedures performed in female patients between 18 and 65 years of age were incl

86 sterior middle cingulate cortex was found in female patients but negative connectivity was found in m

87 d with an increase in all-cause mortality in female patients, but not in male patients with Raynaud p

88 associated with worse disease progression in female patients, but not in male patients.

89 formation, particularly in neutrophils from female patients, by engaging A(1) and A(3) adenosine rec

90 l cortex (PFC) and dorsal posterior INS; (2) female patients compared with male patients had greater

91 the pericarditis group, especially among the female patients, compared to matched control individuals

92 pass surgery persist with Black patients and female patients consistently experiencing worse outcomes

93 cm(2) /m(2) in male and < 39 cm(2) /m(2) in female patients, constitute the validated definition for

94 dividual subjects reported benefits; e.g., a female patient could stand up from sitting on the floor

95 PV is not a monolithic disorder: female patients deregulate fewer genes and clinically be

96 Female patients diagnosed as having stage IV breast canc

97 Using MarketScan data, we identified female patients diagnosed with MBC in 2006-2015.

98 ulcer osteomyelitis, whereas only 28 (4%) of female patients did (OR 2.21, 95% CI 1.39-3.59).

99 and the basal metabolic rate (BMR) in obese female patients during the initial 3 y after an RYGB.

100 l analysis of data obtained on 3121 male and female patients evaluated at the Cooper Clinic in Dallas

101 A 26-year-old female patient exhibited symptoms associated with egg al

102 DR) ranging from 50 to 70% for both male and female patients for the endoscopist from both colonoscop

103 In all, 15,601 female patients from the Herniamed Registry who had unde

104 ion overall and particularly among black and female patients, given their high prevalence of post-MI

105 ods (odds ratio=0.81, 95% CI=0.78-0.85), and female patients had 14% lower odds of substance-related

106 ion (odds ratio=0.65, 95% CI=0.64-0.67), and female patients had 31% lower odds of concurrent substan

107 th months when not receiving medication, and female patients had a 42% (odds ratio, 0.58; 95% CI, 0.5

108 Female patients had a higher chance of relapse than male

109 Female patients had a higher likelihood of complete clin

110 gender-related distributions, we found that female patients had higher axial diameters than men.

111 Female patients had higher incidence of squamous cell ca

112 Similarly, female patients had higher odds of death compared to mal

113 (1031+/-74 versus 954+/-32 ms, P<0.001) and female patients had higher RV T1 compared with males (10

114 this region: (1) male patients compared with female patients had increased positive connectivity of t

115 ality risk scores (11.9 vs. 11.6; p = 0.05), female patients had lower prevalence of coronary artery

116 By contrast, female patients had more robust T cell activation than m

117 Female patients had significantly increased percentages

118 In addition, female patients had significantly lower fractional aniso

119 tissues and found that ERbeta-positive NSCLC female patients had worse survival outcomes than those o

120 Tumors from female patients have a higher frequency of KDM6A mutatio

121 Female patients have a higher prevalence of vasomotor dy

122 Female patients have historically received less aggressi

123 The homozygous female patient in family 1 displayed a severe phenotype.

124 is of molecular differences between male and female patients in 13 cancer types of The Cancer Genome

125 There were 6 male and 3 female patients in Group 1, and the average age of patie

126 There were 5 male and 2 female patients in Group 2 and the average age of patien

127 and sex reversal, such as XY phenotypically female patients in humans.

128 Of 1112 female patients in the registry, 669 (60.2%) had undergo

129 nd race, male patients had higher rates than female patients (incidence rate ratio [IRR], 1.65; 95% C

130 tality was potentially more pronounced among female patients (interaction p = 0.05), but did not diff

131 , controlled trial conducted specifically in female patients is necessary to properly study differenc

132 1 diabetes was slightly raised, whereas for female patients it was 50% higher.

133 t was 67 years (range, 29-94 years), and for female patients, it was 66 years (range, 31-97 years).

134 Insight into the survival advantage of female patients may advance the molecular understanding

135 Among the 133 female patients (mean [SD] age, 37.4 [7.5] years), worse

136 ients (mean age 61 +/- 17 years) and 118,494 female patients (mean age 62 +/- 19 years), with measure

137 n age, 66.1 years; range 36-83 years) and 40 female patients (mean age, 66.8 years; age range, 36-90

138 d deviation]) were compared with those in 40 female patients (mean age, 80.2 years +/- 11.0) with acu

139 as greatest in the TAF-based group and among female patients (mean increase, 6.4 kg in the TAF-based

140 patients (5093 [47.4%] male and 5648 [52.6%] female patients; mean [SD] age, 53.0 [23.0] years).

141 nation for clinical purposes (93 male and 63 female patients; mean age +/- standard deviation, 59.8 y

142 of whom 78 had analyzable data (57 male, 21 female patients; mean age, 66+/-9 years).

143 an age, 48 years; range, 18-67 years) and 14 female patients (median age, 52 years; range, 24-68 year

144 o or trivial mitral regurgitation, and 16 (6 female patients; median age: 40 years) MVP patients with

145 Thirty-six (27 female patients; median age: 44 years) arrhythmic MVP pa

146 raphy was used to record C nociceptors of 30 female patients meeting criteria for fibromyalgia and co

147 rom adrenalectomy, with younger patients and female patients more likely to have a favourable surgica

148 1-year postdischarge angina, with black and female patients more likely to have angina and to be reh

149 ounted for by the multivariate linear model, female patients more strongly agreed that they understoo

150 Female patients (n = 162) with FTV and RFS were included

151 ng of patients within physicians, found that female patients (odds ratio [OR] = 2.58; 95% CI, 1.53-4.

152 Participants were 8 female patients of white race/ethnicity with highly acti

153 A female patient on quinidine for atrial fibrillation who

154 (0.67) (P < 0.0001), a phenomenon driven by female patients (P < 0.0001).

155 The ED50 value was 65% lower in female patients (P = .0001) and 71% lower in all asthmat

156 tratified by gender was seen to be driven by female patients (P = 0.036).

157 sequence of decreased miRNA-96 expression in female patient PASMCs, and this may contribute to the de

158 larger burden of olfactory deficit and older female patients performing better on olfactory tests.

159 This female patient presented in the second decade of life wi

160 18 year old female patient presented to the surgery OPD with complai

161 A 28-year-old female patient presented with complaints of severe abdom

162 A 40-year-old female patient presented with history of headache since

163 A twenty-six years old Ethiopian female patient presented with painless reduction of visi

164 A 52-year-old female patient presented with progressive vision loss in

165 The mean (SD) age of the 5 female patients presented in this case series was 35.2 (

166 Case Report: A middle-aged female patient presenting with a history of multiple chr

167 report the case of a 66-year-old anal cancer female patient presenting with an asymptomatic sub-hepat

168 Median age was 32 years, with female patients presenting at a younger age than male pa

169 Among female patients, procedural mortality trended lower with

170 A 45-year-old female patient received docetaxel treatment after resect

171 cquisitions were performed in 54 consecutive female patients referred for 3-T magnetic resonance (MR)

172 Female patients referred to the British Columbia Cancer

173 tained in those patients (including male and female patients separately) with high versus low MR imag

174 evere atypical psychiatric symptoms in young female patients should raise the index of suspicion for

175 Female patients showed significantly lower volumes of ne

176 Serum testosterone in female patients significantly increased in the AndroGel

177 Female patients spend a longer time on a CVC and are les

178 ase of Bergmeister's papilla (BP) in a young female patient suffering from type 1 sialidosis.

179 ly people (>/=85 years), and were higher for female patients than for male patients of all ages.

180 ety disorder with higher prevalence rates in female patients than in male patients (2.5:1).

181 nemia presented 2.5 times more frequently in female patients than in male patients.

182 of existing cardiac assessments in diabetic female patients to detect myocardial deformation, cardia

183 NASH FibroSure may be used, especially among female patients, to help monitor for risk of worsening f

184 ng were shown in male BPD patients, while in female patients trait anger positively modulated dorsola

185 We present two cases of female patients treated in our department for duodenal d

186 Left ventricular biopsies from 68 male/46 female patients undergoing aortic valve replacement surg

187 ross-sectional analysis of privately insured female patients undergoing immediate breast reconstructi

188 Between 2012 and 2014, 207 female patients undergoing surgery for potential or know

189 reased morbidity and mortality for black and female patients undergoing surgery.

190 Female patients undergoing TAVR had a different risk pro

191 Female patients, unlike male patients, with high volumes

192 of patients with ADHD (N = 3,874,728, 47.8% female patients) using data from commercial health care

193 A 73-year-old female patient was admitted to the Emergency Department

194 A 29-year-old female patient was referred to our department by her oph

195 We found that the AAO of female patients was approximately 5 months earlier than

196 The percentage of female patients was greater in PPP (77.0%) than in GPP (

197 The overall reported incidence of ZVD among female patients was twice that in male patients.

198 One hundred forty-three consecutive female patients were examined by using an image-processi

199 Female patients were more compliant than male patients w

200 Female patients were more sensitive to acetylcholine wit

201 rred with a diagnosis of idiopathic disease, female patients were most commonly affected (121/179; 67

202 Compared with male patients, female patients were older, with a lower prevalence of c

203 Female patients were over-represented in the H tumor gro

204 Two male and three female patients were recruited in this study.

205 age, 11 years +/- 5 [standard deviation]; 10 female patients) were evaluated.

206 tal patients; 286 postpubertal patients; 260 female patients) were evaluated.

207 27 patients (mean age, 38 years +/- 24; 1088 female patients) were used.

208 A female patient who died in 2012 received a diagnosis of

209 We presented a 60-year-old female patient who had both hyperdense middle cerebral a

210 We present a case of a 16 year old female patient who had unilateral loss of vision with si

211 We present a female patient who noted decreased vision after docetaxe

212 We report the case of an adult female patient who presented for a deceased donor kidney

213 CC15 is the most cost-effective strategy for female patients who are between 40 and 60 years of age a

214 This study compares these 2 techniques in female patients who are in need of an elective cholecyst

215 CC10 is the most cost-effective strategy for female patients who are younger than 40 years, and CC15

216 There were 4127 female patients who initiated quadrivalent HPV vaccinati

217 The percentage of female patients who underwent bariatric surgery decrease

218 Materials and Methods Female patients who underwent pelvic US with or without

219 Participants were female patients who were diagnosed as having breast canc

220 the case of an otherwise healthy adolescent female patient, who, despite aggressive management, succ

221 A 40-year old female patient with a four-day history of severe diarrhe

222 is article reports the case of a 46-year-old female patient with a history of a 6-month hypochromic m

223 Here we report a case where a 44 year old female patient with a history of symptomatic anemia and

224 rom a PEODDN lesion of a primary school-aged female patient with bands of hyperkeratotic-affected ski

225 We present a long term follow-up of a young female patient with choroidal infarction, primary open a

226 CASE REPORT: We present a 48-year-old female patient with complaints of abdominal pain and jau

227 pha (ERalpha) was previously identified in a female patient with estrogen insensitivity syndrome.

228 76-year old obese (BMI 32 kg/m(2)), female patient with history of hypertension, stable coro

229 ift mutation was discovered in a 10-year-old female patient with LQTS with a QTc of 500 milliseconds

230 An unvaccinated, young, female patient with measles confirmed by direct epidemio

231 A 43-year-old female patient with metastatic lung adenocarcinoma, who

232 re a new hemoglobin alpha chain variant in a female patient with mild anemia, whose father also carri

233 We report a 29 year old female patient with neck tumor suspected to be a sarcoma

234 ion and a rare promoter variant in HSCB in a female patient with non-syndromic CSA.

235 nduced pluripotent stem cells (iPSCs) from a female patient with TSC with one or two mutations in TSC

236 A 45-year old white female patient with very advanced under treatment JOAG i

237 Twelve unrelated female patients with a clinical and genetic diagnosis of

238 essel occlusion and were mostly diagnosed in female patients with a fair to good interobserver agreem

239 The obese group consisted of 72 female patients with a mean age of 37.27 +/- 1.18 years.

240 The study population included 13 male and 6 female patients with a mean age of 55 years.

241 ere acquired from adolescent and young adult female patients with acute AN (n = 40), recovered patien

242 d hazard ratio, 1.47; 95% CI, 1.32-1.63) and female patients with ADHD (1.45; 1.24-1.71) had an incre

243 open-label parallel-group study in male and female patients with alcohol-related cirrhosis and porta

244 arning and value-based decision making in 36 female patients with AN and 36 age-matched healthy volun

245 Sixty-one adolescent female patients with anorexia nervosa and 45 age- and se

246 hods The cohort consisted of 910 consecutive female patients with BC treated with radiotherapy (RT) a

247 ith a life-time history of poly drug use and female patients with borderline personality disorder are

248 rial/A prospective study was conducted in 28 female patients with breast cancer and with at least one

249 We conducted a prospective study of female patients with CD (age, 16-51 y), identified from

250 akinra versus placebo on fatigue severity in female patients with CFS.

251 ic resonance imaging, we found that male and female patients with chronic neuropathic orofacial pain

252 female patients with noncirrhotic PBC, seven female patients with cirrhotic PBC, and 11 healthy femal

253 tion, there were 30.1% and 25.5% of male and female patients with CKD at very high-risk, respectively

254 Observations: Three eyes from 2 young female patients with classic features of AMN are present

255 Female patients with codes for delivery from the Interna

256 proach to the treatment and care of male and female patients with COVID-19.

257 The HRs for 42-day and 1-year mortality in female patients with DM and CKD were 4.03 (95%CI, 1.40-1

258 analyses to compare the hazard of death for female patients with early-stage invasive ductal carcino

259 and CT may be variously involved in male and female patients with FD cardiomyopathy, affecting CT fun

260 factor analysis suggested that cell death in female patients with GBM is associated with MYC, while t

261 e manner, were more frequent in male than in female patients with HCC (integration: 22/58 male patien

262 bination, 39/62 male patients with HCC, 9/39 female patients with HCC, P < 0.0001).

263 -124G>A: 17/62 male patients with HCC, 3/39 female patients with HCC, P = 0.0201; in combination, 39

264 egration: 22/58 male patients with HCC, 6/36 female patients with HCC, P = 0.0285; -124G>A: 17/62 mal

265 We enrolled female patients with HER2-overexpressing metastatic brea

266 This prospective clinical study compared 96 female patients with iron-deficiency anemia and 60 healt

267 Female patients with LHON had a significantly greater ri

268 he genetic and prognostic characteristics of female patients with lung cancer harboring RET fusion ge

269 racteristics and poor prognosis are found in female patients with lung cancer harboring RET fusion ge

270 he genetic characteristics of RET fusions in female patients with lung cancer is available, this stud

271 a during transplantation in 7 postmenopausal female patients with lymphoma compared to healthy contro

272 M1, GRM4, GRM5 and GRM7 were detected in the female patients with MDD.

273 ate dehydrogenase (G6PD) enzyme activity and female patients with moderate G6PD enzyme deficiency; al

274 s of the CNS of both female SJL EAE mice and female patients with MS compared with their male counter

275 Female patients with MS have higher survival disadvantag

276 idence interval: 0.375, 0.476) compared with female patients with mTBI and control subjects (P < .05)

277 Female patients with MTBI had lower digit span scores th

278 ay suggest a worse working memory outcome in female patients with MTBI.

279 CT symptom scores (P = .33) between male and female patients with mTBI.

280 Female patients with NF1-associated optic glioma were tw

281 Thirteen female patients with noncirrhotic PBC, seven female pati

282 more, serum miR-223 levels were decreased in female patients with PAH associated with congenital hear

283 /-) PASMCs from female mice and hPASMCs from female patients with PAH; this was associated with incre

284 However, in 1968, Zollinger et al reported 2 female patients with pancreatic neuroendocrine tumors, W

285 Cluster 3 patients were obese female patients with reversible airflow obstruction who

286 Male and female patients with severe obesity had a 2.5- to 4-fold

287 myalgia and compared with recordings from 17 female patients with small-fiber neuropathy and 9 female

288 responses to mental stress between male and female patients with stable IHD.

289 is of coronary artery thrombi, we identified female patients with stent thrombosis as the population

290 intervention), compared with NC (control) in female patients with symptomatic cholecystolithiasis.

291 Compared to males, female patients with T2DM had a higher body mass index (

292 vestigating gonadal dysgenesis in phenotypic female patients with the 46, XY karyotype.

293 luster T4 is predominantly composed of obese female patients with uncontrolled severe asthma with inc

294 gs are effective alternatives to surgery for female patients with vulval intraepithelial neoplasia af

295 Marked clinical variability was seen in female patients with XLP owing to random X-chromosomal i

296 Based on data from 272,778 (49% female) patients with a mean (SD) age of 73 years (14) a

297 s more pronounced among elderly individuals, females, patients with conduction disorders, and those t

298 e melanoma patients have worse survival than female patients, yet the detailed mechanisms for this ge

299 nited States that disproportionately affects female patients, young adults, and African American and

300 Between Jan 1, 1996, and June 30, 2012, 410 female patients younger than 18 years at diagnosis were